Table 1.

Drugs Used to Establish Cell Line Resistance Patterns and the Clinically Available Drug Concentrations in the Tumors (C2)

Drug	C2, µg/ml	C2, µM	Supplying Company
Cisplatin	0.5	1.66 × 10−4	Gry-Pharma
Paclitaxel	0.025	0.29 × 10−5	Bristol
Topotecan	0.01	2.18 × 10−3	GlaxoSmithKline